newsfilter.io

Tobacco — industry outlook

  • Period: 2026-08-14 to 2026-09-04
  • Events: 1
  • Generated: 2026-09-04T06:30:00.003Z

European Distribution and Margin Structure

Companies integrating downstream distribution capabilities anticipate structural declines in percentage gross margins as lower-margin logistics activities are consolidated into revenue, even as absolute operating and net profit scales expand. RLX (RLX) expects European gross margins to "settle back to a healthy balance range" in the second half of 2026 following a temporary Q2 spike, noting that the consolidation of its Western European B2B/FMCG platform (covering 50% of independent retail points and 30,000+ endpoints) will drive this shift starting Q3 2026. This strategy is positioned to replace rigid wholesaling with direct channel investments to secure sell-out visibility and shelf space.

Regulatory Barriers to Entry and Market Consolidation

Industry participants view stricter global regulatory environments, including plain packaging and retail display bans, as "risk barriers to entry" that will eliminate non-compliant competition and benefit established players. RLX (RLX) anticipates that consistent enforcement in China will yield "overwhelming positive long-term development" by restoring order to retail channels and redirecting illicit demand to compliant brands, though domestic sales are forecast to remain "broadly flat" for FY2026 due to procedural timelines and tighter enforcement. Conversely, RLX (RLX) notes that legacy tobacco companies may increase competition in Europe through flavored e-cigarettes and Heat-Not-Burn (HNB) products.

Capital Allocation and Shareholder Returns

Management teams across the sector are committing to deploying excess capital toward shareholder returns, specifically share repurchases and dividends, subject to market conditions and board approval. RLX (RLX) explicitly stated its intent to "systematically reserve excess capital" for these purposes. On the M&A front, RLX (RLX) targets "structurally non-dilutive" opportunities with clear cash payback timelines, focusing on larger-scale assets that generate EPS accretion rather than suboptimal marginal returns.

US Market Entry and Regulatory Prerequisites

Company strategies for the US market remain contingent on the establishment of clear regulatory pathways, with no aggressive commercial rollouts planned until long-term credibility is established. RLX (RLX) adopts a "strictly ROI-driven" stance, withholding large-scale capital commitments until PMTA approvals provide certainty, though it notes that non-listed affiliates have applications in "advanced stages." This caution reflects a broader industry trend where commercial execution is secondary to waiting for optimal regulatory conditions, particularly for Heat-Not-Burn products.

Global Capacity and Supply Chain Resilience

To mitigate trade friction and macroeconomic uncertainty, firms are constructing manufacturing hubs in Southeast Asia to improve tariff positions and streamline logistics. RLX (RLX) is currently building a "state-of-the-art manufacturing hub" in Southeast Asia to cover multi-product categories and reduce exposure to geopolitical risks. This infrastructure supports the finalization of Oral Nicotine Pouch capacity, which is expected to become a "meaningful contributor to revenue and profits in the future."

Overseas Growth and H2 2026 Performance

While domestic markets in China face flat growth forecasts, companies express high confidence in delivering "strong overall overseas performance" in the second half of 2026. RLX (RLX) describes Europe as the "cornerstone" of global growth, driven by a "dual-engine model" balancing organic expansion with M&A. This geographic diversification is designed to leverage proprietary channel models in Asia and robust international demand, offsetting the "broadly flat" mainland China sales expected for the full year 2026.